pillbase.ru

Ruxolitinib Zentiva

Active substance: ruxolitinib

ruxolitinib hemifumarate

Centralised EU authorisationActive

Marketing holder: Zentiva k.s.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
  • ruxolitinib hemifumarate
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 11
  • JAKAFI
    TABLET · RUXOLITINIB 10 mg/1
    50881-010
    Incyte Corporation
  • JAKAFI
    TABLET · RUXOLITINIB 20 mg/1
    50881-020
    Incyte Corporation
  • JAKAFI
    TABLET · RUXOLITINIB 5 mg/1
    50881-005
    Incyte Corporation
  • JAKAFI
    TABLET · RUXOLITINIB 15 mg/1
    50881-015
    Incyte Corporation
  • JAKAFI
    TABLET · RUXOLITINIB 25 mg/1
    50881-025
    Incyte Corporation
All products in this country (11)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-6cfd-72ee-a498-1d2e3837c147,01a1208c-6cff-7121-8be2-16e85d7d72c3,01a1208c-6d00-7f2b-8d8b-5330b1dc625a,01a1208d-32f2-7c32-9ca0-d88662df4010,01a1208d-32f6-713b-824b-41e4e8d5968b;count=11 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/006791
Registration status
Active
ATC code
L01EJ01
Sources
  • product · EMA · EMEA/H/C/006791 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/006791 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/006791 · Verified 2026-10-09